Re: Positron Emission Tomography/Computed Tomography-based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-resistant Prostate Cancer
Articolo
Data di Pubblicazione:
2018
Citazione:
Re: Positron Emission Tomography/Computed Tomography-based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-resistant Prostate Cancer / B. Rocco, A. Eissa, G. Bianchi. - In: EUROPEAN UROLOGY. - ISSN 0302-2838. - 73:4(2018), pp. 639-640. [10.1016/j.eururo.2017.12.004]
Abstract:
Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer. [JAMA Oncol. 2018]
Comment on: Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer.
Fox JJ, Gavane SC, Blanc-Autran E, Nehmeh S, Gönen M, Beattie B, Vargas HA, Schöder H, Humm JL, Fine SW, Lewis JS, Solomon SB, Osborne JR, Veach D, Sawyers CL, Weber WA, Scher HI, Morris MJ, Larson SM.
JAMA Oncol. 2018 Feb 1;4(2):217-224. doi: 10.1001/jamaoncol.2017.3588.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Biomarkers; Humans; Male; Multimodal Imaging; Prognosis; Prostatic Neoplasms; Prostatic Neoplasms; Castration-Resistant; Receptors; Androgen; Urology
Elenco autori:
B. Rocco, A. Eissa, G. Bianchi
Link alla scheda completa: